-
Phthalates, chemicals used in some medical devices, could be creating attention deficit in children
Currently in the U.S., six types of phthalates have been banned from use in children’s toys for health risks, but they are still present in so many of the devices that are designed to be flexible or pliable.
-
Boston Scientific gets FDA approval for pacemakers designed to safely undergo MR scans
With the full ImageReady system, patients are approved to get full-body MRI scans, which eliminates some of the potential risks of a device malfunctioning due to the scan.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Sisu Global Health announces new funding for its Hemafuse blood recycling device
The handheld device, the Hemafuse, allows doctors to recycle blood from patients with internal bleeding, reducing the need for donor blood. It collects blood from an internal hemorrhage and is designed to be used in emergency situations.
-
FDA proposes ban on electrical stimulation devices that treat aggressive behavior
The regulatory agency said there are psychological and physical risks associated with use of such devices, including depression, anxiety and what appears to resemble PTSD. In addition to psychological effects, there have been reports of burns, tissue damage and shocks.
-
Divurgent and Sensato put together new medical device cybersecurity task force
The goal is to develop best practices for healthcare organizations and device manufacturers.
-
J&J’s LifeScan launches KnowMyCoPay, site lowering prices for diabetic test strips
LifeScan, Inc. has announced KnowMyCoPay, which is a website and toll-free phone service, free of charges, that will allow patients to find the lowest copays for diabetes test strips.
-
Medtronic is recalling a battery pack used in patient monitors
Apparently, the battery packs, used in its Coviden Oridon Capnostream 20 and Capnostream 20p, could cause “thermal damage.” The devices are used to check respiratory status and keep tabs on breathing regularity.
-
Magellan launches digital smoking cessation program
Magellan Health Inc., which has created Click Therapeutics and Digital Therapeutic solutions, today announced a digital, integrated and comprehensive smoking cessation program.
-
ResApp brings in $12.5M for technology designed to treat respiratory disease
For illnesses, such as pneumonia, each person creates a unique sound signature when they cough. Based on four to five coughs, signal-processing algorithms in this app can detect those patterns, identifying both the type and severity of an ailment.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Morning Read: UnitedHealth will only be in “handful” of health insurance exchanges in 2017
Enterome Bioscience, a developer in pharmaceuticals and diagnostics based on the gut microbiome, announced new financing, and researchers have discovered a molecular structure that could aid the design of broad-spectrum antibiotics.
-
Why isn’t there more data collection to identify which medical devices are safe?
The Brookings Institution reported that medical devices contribute to about 3,000 deaths each year in the United States — but that number could be lower than what’s accurate, considering how medical device safety is currently being tracked in comparison to things like pharmaceuticals.
-
Teenagers today have spent a third of their lives looking at a screen. What does that mean for vision health?
New findings from VSP Vision Care indicate that by the time an average American child reaches the age of 17, they have spent nearly 6 years looking at digital devices.
-
Helius Medical brings in $7M for portable neuromodulation stimulator
The proceeds are said to be used to finish a clinical registry trial of its portable neuromodulation stimulator in treating traumatic brain injury.
-
Nevro gets FDA pre-market approval for spinal cord stimulation device
The Redwood City, California-based company previously got an FDA nod in May 2015 for the device, which delivers high-frequency electrical impulses of up to 10,000Hz to the spinal cord to avoid the tingling sensation known as paresthesia (HF10 therapy).
-
Devices & Diagnostics, Diagnostics
Best of INVEST: Trice Medical’s mi-eye device for rapid joint injury diagnosis
Trice Medical has created an innovative device, mi-eye, that in majority of cases eliminates the need for an MRI and for multiple doctor visits.